SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 2, 2018
Document Date
Apr 2, 2018
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Aquestive Therapeutics
Issuer
Aquestive Therapeutics, Inc.
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds